7:00 a.m.

Registration and Continental Breakfast—Exhibits Open

7:45 a.m.

Welcome and Opening Remarks, Daniel Weisdorf, MD, University of Minnesota Health; and OptumHealth Education

8:00 a.m.

Blood/Marrow Transplantation (BMT): The Donor Selection Process, Claudio Brunstein, MD, University of Minnesota Health

Learning Objectives:

1. Describe matched related donors, unrelated donors and alternative donors for BMT.
2. Identify determining factors when selecting a donor and stem cell source for an allogeneic BMT.

8:45 a.m.

Current Management Options for Multiple Myeloma; Making Sense of Alphabet Soup, Brian McClune, DO, University of Minnesota Health

Learning Objectives:

1. Define when myeloma requires treatment and important prognostic markers.
2. Discuss treatment options for non-transplant eligible patients.
3. List first and second generation novel agents.
4. Review treatment options for transplant-eligible patients and those that have relapsed.

9:30 a.m.

Break—Exhibits Open

9:45 a.m.

Novel Uses of Cellular Therapies, Sarah Cooley, MD, MS, University of Minnesota Health

Learning Objectives:

1. Describe emerging trends in the use of cellular therapies.

10:30 a.m.

Treatment and Management of Myelodysplastic Syndrome (MDS): Strategies to Optimize Outcomes, Erica Warlick, MD, University of Minnesota Health

Learning Objectives:

1. Define the role of transplantation for MDS.
2. Discuss the appropriate timing for transplantation for MDS in the context of alternative available therapies.
3. Compare and contrast transplantation for MDS with non-hematopoietic-stem-cell transplant therapy.
4. Identify the appropriate therapies for lower- and higher-risk MDS and the novel agents being developed.

11:15 a.m.

Lunch (provided)—Exhibits Open

12:30 p.m.

Acute Myelogenous Leukemia (AML), Celalettin Ustun, MD, University of Minnesota Health

Learning Objectives:

1. Identify evolving molecular markers and treatment options.
2. Identify appropriate therapeutic strategies for the older patient with AML.
3. Discuss why the consideration of performance status, comorbidities and quality of life are important for successful long-term treatment goals.

1:15 p.m.

BMT as a Treatment Option for Pediatric Niche Diseases, Paul Orchard, MD, University of Minnesota Health

Learning Objectives:

1. Identify types of rare niche diseases wherein transplant is an option.
2. Discuss outcomes of allogeneic BMT for the treatment of inherited inborn errors of metabolism.

2:00 p.m.

Break—Exhibits Open

2:15 p.m.

Diagnosis, Treatment and Outcomes for Patients With Lymphoma, Veronika Bachanova, MD, University of Minnesota Health

Learning Objectives:

1. State the different types of lymphoma.
2. Review the diagnosis, treatment and survival rates of Hodgkin and non-Hodgkin lymphoma.

3:00–4:00 p.m.

Unrelated Cord Blood and Epidermolysis Bullosa as a Novel Therapeutic Application, John Wagner, MD, University of Minnesota Health

Learning Objectives:

1. Describe transplant outcome expectations in recipients of unrelated cord blood transplantation in relation to other stem cell sources.
2. Discuss risk factors for engraftment, relapse and event-free survival after unrelated cord blood transplant.
3. Review outcomes in recipients of ex vivo expansion of umbilical cord blood hematopoietic stem cells and regulatory T cells as strategies to speed hematopoietic recovery and reduce the risk of graft-versus-host disease.
4. Review the rationale and transplant outcomes in patients with severe epidermolysis bullosa.

4:00 p.m.

Adjourn

7:00 a.m.

Registration and Continental Breakfast—Exhibits Open

7:45 a.m.

Welcome and Opening Remarks, John R. Lake, MD, and Timothy Pruett, MD, Co-Directors Transplant Services, University of Minnesota Health; and OptumHealth Education

8:00 a.m.

Ethics and Efficacy in Transplant, John R. Lake, MD, and Timothy Pruett, MD

Learning Objectives:

1. Review the topics surrounding transplant ethics.
2. Describe efficacy as it relates to transplant and the power to produce desired results.

9:00 a.m.
Updated 5/4/15

Current Management of Cystic Fibrosis, Jordan Dunitz, MD, University of Minnesota Health

Learning Objectives:

1. Discuss evidence-based therapies for patients with cystic fibrosis.
2. Discuss appropriate timing of transplant necessary for patients with CF.

9:30 a.m.

Challenges of Donor-Specific Antibodies and Paired Exchange, Ty Dunn, MD, MS, University of Minnesota Health

Learning Objectives:

1. Explain what makes up donor-specific antibodies.
2. Review how having high donor-specific antibodies affects the patient’s ability to get a transplant.
3. Describe paired exchange and its impact on increasing the number of transplants.

10:00 a.m.

Break—Exhibits Open

10:15 a.m.

Focused Quality Assessment and Performance Improvement (QAPI), Rebecca A. Stepan, MPH, RD, CPHQ, LSSBB, and Michelle James, MS, RN, CNS, CCTN, APRN-BC, University of Minnesota Health

Learning Objectives:

1. Describe QAPI in transplant.
2. Discuss one example of a QAPI project.

11:00 a.m.
Updated 5/4/15

Pediatric Total Pancreatectomy With Islet Auto-Transplantation (TPIAT), Srinath Chinnakotla, MD, University of Minnesota Health

Learning Objectives:

1. Explain the criteria for pediatric patients to be eligible for TPIAT.
2. Describe how the process works and the patient outcomes.

11:30 a.m.

Challenges in the Care of Interstitial Lung Disease (ILD), Rade Tomic, MD, University of Minnesota Health

Learning Objectives:

1. Describe the pathophysiology of interstitial lung disease.
2. Explain the impact of ILD on the posttransplant recovery process.

12:00 p.m.

Lunch (provided)—Exhibits Open

1:15 p.m.

What’s New in the Treatment of Hepatitis C, Julie Thompson, MD, University of Minnesota Health

Learning Objectives:

1. Describe the mechanism of action for new hepatitis C virus (HCV) drugs.
2. Discuss the impact of HCV on liver transplantation.

2:00 p.m.

“Don’t Rule Me Out”—Donor Availability, William D. Payne, MD, University of Minnesota Health

Learning Objectives:

1. Discuss one new strategy for the medical management of potential organ donors.
2. Explain why age is no longer a driving factor in being a donor.

2:45 p.m.

Break—Exhibits Open

3:00 p.m.

Increased Donor Utilization Through Breathing Lung Transplantation Using the Organ Care System (OCS), Gabriel Loor, MD, University of Minnesota Health

Learning Objectives:

1. Describe how the quality of a potential donor lung is improved with ex vivo lung perfusion (EVLP).
2. Explain how EVLP increases the donor pool.

3:45–4:30 p.m.

Adult and Pediatric Congenital Heart Disease, Cindy M. Martin, MD, University of Minnesota Health, and Rebecca Ameduri, MD, University of Minnesota Masonic Children’s Hospital

Learning Objectives:

1. Describe the unique considerations for a patient with congenital heart disease in heart transplantation.

4:30 p.m.

Adjourn